Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma

INTRODUCTION: The purpose of this study was to analyze the safety and feasibility of low-dose apatinib combined with S-1 as a second-line therapy or beyond in Chinese patients with pulmonary and/or hepatic metastases of nasopharyngeal carcinoma (NPC). METHODS: Forty-one Chinese NPC patients with pul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Liya, Lin, Jie, Wu, Gang, Chen, Jiawei, Huang, Xiaopeng, Zhang, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125328/
https://www.ncbi.nlm.nih.gov/pubmed/32280197
http://dx.doi.org/10.2147/DDDT.S244102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125328/
https://www.ncbi.nlm.nih.gov/pubmed/32280197
http://dx.doi.org/10.2147/DDDT.S244102

Ejemplares similares